De Novo device
Dexcom Share Direct Secondary Displays
Dexcom, Inc. · Continuous Glucose Monitor Secondary Display (PJT, Class II) · First FDA decision Jan 23, 2015, newest Jan 23, 2015Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
7
Naming "Share Direct"
MAUDE reports
0
Brand "Share Direct", since 2015
PubMed studies
0
Mentioning "Share Direct"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dexcom Share Direct Secondary Displays
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38662CGS Administrators, LLCUpdated Sep 29, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38623Wellpoint FederalUpdated Jul 14, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38686WPS Insurance CorporationUpdated Jun 18, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38657Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38743Palmetto GBAUpdated Jul 19, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38664First Coast Service Options, Inc.Updated Jun 21, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38617Novitas Solutions, Inc.Updated Jun 21, 2024
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Share Direct", any status and sponsor, newest update first.
Imam Abdulrahman Bin Faisal UniversityAcademic, hospital or other
NCT07921784 · 66 participants (planned) · Start Oct 15, 2026 · Primary completion Jun 15, 2027
Device: Instrument Assisted Soft Tissue Mobilization; Sham Instrument-Assisted Soft Tissue Mobilization · For: Low Back Pain; Trigger Point Pain, Myofascial
- Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart FailurePivotal-lookingRecruiting
University of California, San FranciscoAcademic, hospital or other
NCT03586336 · 100 participants (planned) · Start Dec 1, 2018 · Primary completion Dec 31, 2027
Device: ReDS-Guided; Usual Care · For: Heart Failure; With Decompensation
Sites: San Francisco, California
Sirtex MedicalNot on our public-company list
NCT07663487 · 78 participants (planned) · Start Oct 2026 · Primary completion Oct 2029
Device: SIR-Spheres Selectively Delivered to Liver Tumor · For: Hepatocellular Carcinoma (HCC)
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Share Direct", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PJT
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Share Direct"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PJT.
- MiniMed Connect kitMedtronic Minimed, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.